Jean M. Franchi's Net Worth
$4.76 Million
Who is Jean M. Franchi?
Jean M. Franchi has an estimated net worth of $4.76 Million. This is based on reported shares across multiple companies, which include Replimune Group, Inc., Dimension Therapeutics, Inc., MERRIMACK PHARMACEUTICALS INC, BIODESIX INC, and Disc Medicine, Inc..
SEC CIK
Jean M. Franchi's CIK is 0001653053
Past Insider Trading and Trends
2023 was Jean M. Franchi's most active year for acquiring shares with 6 total transactions. Jean M. Franchi's most active month to acquire stocks was the month of March. 2021 was Jean M. Franchi's most active year for disposing of shares, totalling 5 transactions. Jean M. Franchi's most active month to dispose stocks was the month of December. 2020 saw Jean M. Franchi paying a total of $352,000.00 for 81,350 shares, this is the most they've acquired in one year. In 2020 Jean M. Franchi cashed out on 50,000 shares for a total of $1,086,199.51, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Replimune Group, Inc. (REPL) Snapshot price: $10.88
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.10% | -11.35K |
$18.05 | -$204,885.55 | 128.75K |
May 16
| |||
Form 4
| +47.32% | 45K |
—
|
—
| 140.1K |
Apr 1
| |||
Form 4
| -3.49% | -3.44K |
$14.59 | -$50,131.24 | 95.1K |
May 16
| |||
Form 4
| +114.04% | 52.5K |
—
|
—
| 98.53K |
Apr 1
| |||
Form 4
|
∞
| 46.03K |
—
|
—
| 46.03K |
Apr 1
| |||
Form 4
|
—
|
0
|
$29.31 | -$456,684.00 |
0
|
Scheduled
|
Jan 13 - Jan 14
| ||
Form 4
|
—
|
0
|
$28.77 | -$734,199.51 |
0
|
Scheduled
|
Dec 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dimension Therapeutics, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MERRIMACK PHARMACEUTICALS INC (MACK) No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIODESIX INC (BDSX) Snapshot price: $2.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
| +307.96% | 61.73K |
$1.62 | $99,999.36 | 81.77K |
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
∞
| 20.04K |
—
|
—
| 20.04K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Disc Medicine, Inc. (IRON) Snapshot price: $50.35
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 36.67K |
—
|
—
| 36.67K |
Feb 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||